S&P 500   3,316.73 (-0.15%)
DOW   29,096.98 (-0.31%)
QQQ   223.99 (+0.05%)
MSFT   166.03 (+0.20%)
GOOGL   1,485.29 (+0.08%)
AMZN   1,881.52 (-0.31%)
NVDA   251.70 (+0.66%)
BABA   217.38 (-2.24%)
GE   11.70 (+2.90%)
TSLA   563.26 (-1.11%)
AMD   51.26 (-0.33%)
T   38.61 (-1.10%)
ACB   2.04 (+0.00%)
F   9.03 (-1.42%)
NFLX   342.88 (+5.18%)
BAC   34.00 (-1.08%)
DIS   141.72 (-1.59%)
GILD   63.15 (-0.44%)
S&P 500   3,316.73 (-0.15%)
DOW   29,096.98 (-0.31%)
QQQ   223.99 (+0.05%)
MSFT   166.03 (+0.20%)
GOOGL   1,485.29 (+0.08%)
AMZN   1,881.52 (-0.31%)
NVDA   251.70 (+0.66%)
BABA   217.38 (-2.24%)
GE   11.70 (+2.90%)
TSLA   563.26 (-1.11%)
AMD   51.26 (-0.33%)
T   38.61 (-1.10%)
ACB   2.04 (+0.00%)
F   9.03 (-1.42%)
NFLX   342.88 (+5.18%)
BAC   34.00 (-1.08%)
DIS   141.72 (-1.59%)
GILD   63.15 (-0.44%)
S&P 500   3,316.73 (-0.15%)
DOW   29,096.98 (-0.31%)
QQQ   223.99 (+0.05%)
MSFT   166.03 (+0.20%)
GOOGL   1,485.29 (+0.08%)
AMZN   1,881.52 (-0.31%)
NVDA   251.70 (+0.66%)
BABA   217.38 (-2.24%)
GE   11.70 (+2.90%)
TSLA   563.26 (-1.11%)
AMD   51.26 (-0.33%)
T   38.61 (-1.10%)
ACB   2.04 (+0.00%)
F   9.03 (-1.42%)
NFLX   342.88 (+5.18%)
BAC   34.00 (-1.08%)
DIS   141.72 (-1.59%)
GILD   63.15 (-0.44%)
S&P 500   3,316.73 (-0.15%)
DOW   29,096.98 (-0.31%)
QQQ   223.99 (+0.05%)
MSFT   166.03 (+0.20%)
GOOGL   1,485.29 (+0.08%)
AMZN   1,881.52 (-0.31%)
NVDA   251.70 (+0.66%)
BABA   217.38 (-2.24%)
GE   11.70 (+2.90%)
TSLA   563.26 (-1.11%)
AMD   51.26 (-0.33%)
T   38.61 (-1.10%)
ACB   2.04 (+0.00%)
F   9.03 (-1.42%)
NFLX   342.88 (+5.18%)
BAC   34.00 (-1.08%)
DIS   141.72 (-1.59%)
GILD   63.15 (-0.44%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSEARCA:UVXY - ProShares Ultra VIX Short-Term Futures ETF Stock Price, Forecast & News

$11.10
+0.27 (+2.49 %)
(As of 01/23/2020 01:23 PM ET)
Add
Today's Range
$10.89
Now: $11.10
$11.38
50-Day Range
$10.58
MA: $12.85
$16.19
52-Week Range
$10.40
Now: $11.10
$69.52
Volume785,971 shs
Average Volume15.12 million shs
Market Capitalization$500.40 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
ProShares Ultra VIX Short-Term Futures ETF seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the S&P 500 VIX Short-Term Futures Index. UVXY provides leveraged exposure to the S&P 500 VIX Short-Term Futures Index, which measures the returns of a portfolio of monthly VIX futures contracts with a weighted average of one month to expiration.

Basic Details

Issuer ProShares
Fund NameProShares Ultra VIX Short-Term Futures ETF
Tax ClassificationPartnership
SymbolNYSEARCA:UVXY
Inception Date10/3/2011
Fund ManagerRyan Dofflemeyer
WebN/A
PhoneN/A

Fund Focus

Asset ClassMulti Asset
BenchmarkS&P 500 VIX Short-Term Futures Index
CategoryAbsolute Returns
FocusVolatility
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$486.08 million
Average Daily Volume$12.00 million
Discount/Premium-0.04%

ETF Expenses

Management Fee0.95%
Other Expenses0.36%
Total Expenses1.31%
Fee Waiver0.00%
Net Expenses1.31%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorProShare Advisors LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
TrusteeWilmington Trust Company
Lead Market MakerVirtu Financial

Receive UVXY News and Ratings via Email

Sign-up to receive the latest news and ratings for UVXY and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of ProShares Ultra VIX Short-Term Futures ETF (NYSEARCA:UVXY)
Currency Exposure of ProShares Ultra VIX Short-Term Futures ETF (NYSEARCA:UVXY)

(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

ProShares Ultra VIX Short-Term Futures ETF (NYSEARCA:UVXY) Frequently Asked Questions

What is ProShares Ultra VIX Short-Term Futures ETF's stock symbol?

ProShares Ultra VIX Short-Term Futures ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "UVXY."

Has ProShares Ultra VIX Short-Term Futures ETF been receiving favorable news coverage?

News articles about UVXY stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ProShares Ultra VIX Short-Term Futures ETF earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave headlines about the exchange traded fund a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for ProShares Ultra VIX Short-Term Futures ETF.

What other stocks do shareholders of ProShares Ultra VIX Short-Term Futures ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra VIX Short-Term Futures ETF investors own include SPDR S&P 500 ETF Trust (SPY), Tesla (TSLA), Direxion Daily Gold Miners Bull 3x Shares (NUGT), Bank of America (BAC), Netflix (NFLX), NVIDIA (NVDA), Alibaba Group (BABA), Cisco Systems (CSCO), Intel (INTC) and Micron Technology (MU).

Who are ProShares Ultra VIX Short-Term Futures ETF's major shareholders?

ProShares Ultra VIX Short-Term Futures ETF's stock is owned by a variety of of retail and institutional investors. Top institutional investors include SeaCrest Wealth Management LLC (0.10%).

Which institutional investors are buying ProShares Ultra VIX Short-Term Futures ETF stock?

UVXY stock was acquired by a variety of institutional investors in the last quarter, including SeaCrest Wealth Management LLC.

How do I buy shares of ProShares Ultra VIX Short-Term Futures ETF?

Shares of UVXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProShares Ultra VIX Short-Term Futures ETF's stock price today?

One share of UVXY stock can currently be purchased for approximately $11.10.

How big of a company is ProShares Ultra VIX Short-Term Futures ETF?

ProShares Ultra VIX Short-Term Futures ETF has a market capitalization of $500.40 million. View Additional Information About ProShares Ultra VIX Short-Term Futures ETF.


MarketBeat Community Rating for ProShares Ultra VIX Short-Term Futures ETF (NYSEARCA UVXY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  219
MarketBeat's community ratings are surveys of what our community members think about ProShares Ultra VIX Short-Term Futures ETF and other stocks. Vote "Outperform" if you believe UVXY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UVXY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel